Opicapone Completed Phase 1 Trials for Epilepsies Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02305329 | Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation |
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02305329 | Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation |